The GSTP1 Ile105Val polymorphism has been widely investigated as a risk biomarker for various cancers, such as chronic myeloid leukemia [14], esophageal cancer [15], and bladder cancer [16], among others. This evidence concerns the gene GSTP1 and esophageal cancer.